-=Nu Skin (NUS) reported earnings on Thur 2 Aug 2018 (a/h)

Nu Skin beats by $0.02, beats on revs; guides Q3 EPS and revs above consensus; guides FY18 EPS in-line, revs above consensus; increases stock repurchase authorization to $500 mln 

• Reports Q2 (Jun) earnings of $0.95 per share, excluding non-recurring items, $0.02 better thanthe Capital IQ Consensus of $0.93; revenues rose 28.0% year/year to $704.19 mln vs the $642.16 mln Capital IQ Consensus.
• Co issues upside guidancefor Q3, sees EPS of $0.97-1.02, excluding non-recurring items, vs. $0.96 Capital IQ Consensus Estimate; sees Q3 revs of $650-670 mln vs. $640.25 mln Capital IQ Consensus Estimate.
• Co issues guidancefor FY18, sees EPS of $3.66-3.81, excluding non-recurring items, vs. $3.72 Capital IQ Consensus Estimate; sees FY18 revs of $2.63-2.67 bln vs. $2.53 bln Capital IQ Consensus Estimate.
• Note: The Q2 results and Q3 and FY18 EPS guidance excludes a purchase accounting charge.
• Co also increases its stock repurchase authorization to $500 mln, an approximate $408 mln increase.